CD40LG and atherosclerosis: Soluble CD40L (sCD40L) is rapidly released from those after activation and has been widely studied as a marker of inflammatory states and autoimmune diseases, including atherosclerosis, rheumatoid arthritis, and systemic lupus erythematosus [23,24,25].